Prenetics Announces CEO Danny Yeung Keynote at Token 2049 Singapore

Rhea-AI Summary

Prenetics Global Limited (NASDAQ: PRE), a consumer health sciences company, announced CEO Danny Yeung will deliver a keynote at Token 2049 in Singapore on October 2, 2025. The presentation will focus on IM8, their supplement brand, and their Bitcoin treasury strategy.

The company currently holds 248.42 BTC at an average price of $108,600 per BTC, with a strategy to acquire 1 Bitcoin daily. Their supplement brand IM8 is projected to achieve $100 million in annual recurring revenue within its first year. Prenetics maintains a strong financial position with $63.5 million in current assets, including $46.3 million from ACT Genomics divestment, $17.2 million in cash, and other assets.

Positive

• IM8 supplement brand projected to reach $100M annual recurring revenue in under 12 months
• Strong balance sheet with $63.5M in current assets
• Strategic Bitcoin holdings of 248.42 BTC with systematic daily acquisition plan
• Successful execution of Bitcoin treasury strategy with average purchase price of $108,600 per BTC

Negative

• Significant exposure to volatile cryptocurrency assets through Bitcoin treasury strategy
• Large capital allocation to Bitcoin could impact operational flexibility

- Keynote: “IM8: The World’s Fastest-Growing Supplement Brand Powering Our Bitcoin Treasury

- Prenetics currently holds 246 BTC with a NAV of $28M

- Prenetics has $63.5m of cash¹

CHARLOTTE, N.C., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics”), a leading consumer health sciences company, today announced Chief Executive Officer, Danny Yeung will deliver a keynote address at Token 2049, one of the world’s premier crypto and blockchain conferences, taking place in Singapore.

Danny is scheduled to present on Thursday, October 2, 2025, joining an influential lineup of global thought leaders, innovators, and investors. His keynote, “IM8: The World’s Fastest-Growing Supplement Brand Powering Our Bitcoin Treasury,” will emphasize Prenetics’ unique position as one of the only fast-growing operating companies to also build a sizable digital asset treasury. While most DAT strategies are pursued by firms without a core operating business, Prenetics stands apart due to IM8’s explosive growth to systematically acquire 1 Bitcoin on a daily basis to continually strengthen its balance sheet.

The presentation will also highlight IM8’s extraordinary momentum—on track to surpass $100 million in annual recurring revenue in less than 12 months since launch, an unprecedented milestone in the supplement industry and a powerful validation of its disruptive model at the intersection of health and wealth.

Bitcoin Treasury Strategy Initiative:

Earlier this year, in June 2025, Prenetics announced the adoption of a corporate Bitcoin strategy. The strategy includes allocating a large majority of the Company’s balance sheet to Bitcoin and integrating Bitcoin across its operations.

The program began with an initial purchase of 187.42 BTC for approximately USD $20 million at an average price of $106,712 per BTC. Since August 1, 2025, Prenetics has followed a disciplined programmatic approach, acquiring Bitcoin daily. As of today, the Company holds 248.42 BTC at an average purchase price of approximately $108,600, underscoring both the scale and commitment of its treasury strategy.

Looking ahead, Prenetics plans to continue its daily acquisition of one Bitcoin through the end of 2025, with expectations to increase the accumulation rate in 2026 as operating cash generation continues to strengthen. Real-time access to the Company’s Bitcoin holdings can be found here.

¹Represents current assets, including estimated proceeds from the divestment of ACT Genomics in the form of $46.3 million to be settled in cash, cash and cash equivalents totaling $17.2 million, financial assets at fair value through profit or loss of $10.5 million, and trade receivables of $1.8 million, amongst other accounting line items under current assets as of June 30, 2025.

About Prenetics

Prenetics (NASDAQ:PRE), a leading health sciences company, is dedicated to advancing consumer and clinical health. Our consumer initiative is led by IM8, a fast growing health and wellness brand, Europa, one of the largest sports distribution companies in the USA and CircleDNA, a leading direct to consumer DNA test. Each of Prenetics’ units synergistically enhances our global impact on health, embodying our commitment to ‘enhancing life through science’. To learn more about Prenetics, please visit prenetics.com.

About Token 2049

Token 2049 is the premier crypto event, organized annually in Singapore, that brings together the world’s leading founders, executives, investors, developers, and media to discuss global developments and trends in the digital asset industry.

Investor Relations Contact:

investors@prenetics.com
PRE@mzgroup.us

Angela Cheung
Investor Relations / Corporate Finance
Prenetics Global Limited
angela.hm.cheung@prenetics.com

FAQ

What is Prenetics' (PRE) current Bitcoin holdings and acquisition strategy?

Prenetics holds 248.42 BTC at an average price of $108,600 per BTC and is acquiring 1 Bitcoin daily through 2025, with plans to increase accumulation in 2026.

How much revenue is Prenetics' IM8 supplement brand expected to generate?

IM8 is projected to exceed $100 million in annual recurring revenue within its first 12 months of launch.

What is Prenetics' current cash position as of June 2025?

Prenetics has $63.5 million in current assets, including $46.3M from ACT Genomics divestment, $17.2M in cash, and other assets.

When and where will Prenetics CEO Danny Yeung present at Token 2049?

Danny Yeung will deliver his keynote presentation on Thursday, October 2, 2025 at Token 2049 in Singapore.

What is unique about Prenetics' Bitcoin treasury strategy?

Prenetics is one of the few operating companies with a core business (IM8) that is using its growth to systematically acquire Bitcoin daily to strengthen its balance sheet.